Select Medical (NYSE:SEM) Price Target Cut to $21.00 by Analysts at UBS Group

Select Medical (NYSE:SEM) had its target price decreased by investment analysts at UBS Group from $40.00 to $21.00 in a report released on Friday,Benzinga reports. The firm currently has a “neutral” rating on the health services provider’s stock. UBS Group’s target price would suggest a potential upside of 11.76% from the company’s previous close.

SEM has been the subject of a number of other reports. StockNews.com lowered shares of Select Medical from a “buy” rating to a “hold” rating in a research report on Monday. Royal Bank of Canada increased their target price on shares of Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a research report on Monday, November 4th. Finally, Benchmark downgraded shares of Select Medical from a “buy” rating to a “hold” rating in a research note on Monday, November 25th. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $39.50.

Select Medical Stock Down 0.3 %

Shares of NYSE:SEM opened at $18.79 on Friday. The firm has a 50 day simple moving average of $27.17 and a 200 day simple moving average of $32.32. Select Medical has a 52 week low of $18.02 and a 52 week high of $40.98. The company has a debt-to-equity ratio of 1.37, a quick ratio of 1.13 and a current ratio of 1.13. The company has a market cap of $2.43 billion, a PE ratio of 8.78, a price-to-earnings-growth ratio of 0.39 and a beta of 1.43.

Select Medical (NYSE:SEM) last issued its earnings results on Thursday, October 31st. The health services provider reported $0.43 EPS for the quarter, topping the consensus estimate of $0.36 by $0.07. The business had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.74 billion. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. Select Medical’s revenue was up 5.7% compared to the same quarter last year. During the same quarter last year, the firm posted $0.46 earnings per share. As a group, research analysts expect that Select Medical will post 1.97 earnings per share for the current year.

Insiders Place Their Bets

In related news, Director Marilyn B. Tavenner sold 32,000 shares of the company’s stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $21.09, for a total transaction of $674,880.00. Following the completion of the sale, the director now directly owns 22,000 shares of the company’s stock, valued at approximately $463,980. This represents a 59.26 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Robert G. Breighner, Jr. sold 4,989 shares of Select Medical stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $19.95, for a total transaction of $99,530.55. Following the completion of the transaction, the vice president now owns 30,356 shares in the company, valued at $605,602.20. This trade represents a 14.12 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 19.14% of the company’s stock.

Institutional Trading of Select Medical

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Quarry LP bought a new stake in shares of Select Medical in the third quarter valued at about $30,000. Canada Pension Plan Investment Board acquired a new stake in shares of Select Medical during the 2nd quarter worth approximately $39,000. DekaBank Deutsche Girozentrale bought a new stake in shares of Select Medical during the second quarter valued at approximately $60,000. GAMMA Investing LLC raised its stake in shares of Select Medical by 16.6% in the third quarter. GAMMA Investing LLC now owns 2,313 shares of the health services provider’s stock valued at $81,000 after purchasing an additional 330 shares in the last quarter. Finally, Wilmington Savings Fund Society FSB bought a new position in Select Medical in the third quarter worth $81,000. Institutional investors and hedge funds own 89.48% of the company’s stock.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.